Special Issue "Triazole and Derivatives in Medicinal Chemistry"
Deadline for manuscript submissions: 15 February 2024 | Viewed by 832
The development of modern medicinal chemistry has tightened the heterocycles with biological activities. Several derivatives of heterocyclic compounds have found applications in various medical fields. Triazole, a five-member heterocycle with 3 nitrogen and 2 carbon atoms, is a significant backbone in medicinal chemistry. This backbone could be found in the structure of many commercial drugs. Since it is readily available through click chemistry to create compound collections against various diseases, it has become an emerging area of interest for medicinal chemists. As is widely known, triazole is the building block for numerous drugs with therapeutic benefits, including antimicrobial, antiviral, anticancer, anti-inflammatory, analgesic, anti-tuberculosis, and antidiabetic activities. In addition, this compound can form complexes with different compounds to form materials with catalytic and biological activities. Regarding the significance of this heterocycle, several researchers have focused on the synthesis of novel compounds based on triazoles and studying their biological activities. Although research efforts are focusing on the development of synthetic triazole analogs, there is still plenty of room for a breakthrough in drug discovery in this field. The potential therapeutic benefits of this moiety have motivated medicinal chemists to create innovative triazole derivatives.
This Special Issue of Pharmaceuticals focuses on "Triazole and Derivatives in Medicinal Chemistry” and invites both reviews and original articles regarding their findings in this field.
I look forward to receiving your contributions.
Dr. Saeed Bahadorikhalili
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- medicinal chemistry
- pharmaceutical chemistry
- organic synthesis
- catalytic organic synthesis